e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Epidemiology and management of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
J. P. De Torres, J. P. Wisnivesky, G. Bastarrica, L. Seijo, A. B. Alcaide, A. Campo, A. Villanueva, J. Pueyo, M. D. Lozano, L. Montuenga, J. J. Zulueta (Pamplona, Spain; New York, United States Of America)
Source:
Annual Congress 2009 - Epidemiology and management of lung cancer
Session:
Epidemiology and management of lung cancer
Session type:
E-Communication Session
Number:
4689
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. P. De Torres, J. P. Wisnivesky, G. Bastarrica, L. Seijo, A. B. Alcaide, A. Campo, A. Villanueva, J. Pueyo, M. D. Lozano, L. Montuenga, J. J. Zulueta (Pamplona, Spain; New York, United States Of America). Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema. Eur Respir J 2009; 34: Suppl. 53, 4689
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Prevalence of bronchiectasis in a lung cancer screnning program
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Lung cancer screening in COPD patients.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Prevalence and characterization of interstitial lung disease in a lung cancer screening program
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Management of concomitant COPD in patients with lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018
Lung cancer in COPD patients
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009
Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort
Source: Eur Respir J, 49 (5) 1601162; 10.1183/13993003.01162-2016
Year: 2017
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Interstitial lung diseases in a lung cancer screening trial
Source: Eur Respir J 2011; 38: 392-400
Year: 2011
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Prevalence and burden of bronchiectasis in a lung cancer screening program
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019
The burden of emphysema on lung cancer prognosis
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
COPD in patients with lung cancer and smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 519s
Year: 2005
Lung cancer in COPD
Source: Eur Respir Mon 2013; 59: 174-188
Year: 2013
Bilateral lung cancer with COPD or metastatic disease
Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept